11 July 2018 – For the second year we are now supporting ARMMAN’s scale-up to reach ~900,000 women (i.e. ~60% projected pregnancies) in Delhi slum areas and their important work to reduce maternal and child mortality and illness in India. ARMMAN’s leverages technology to share educative information with pregnant women and new mothers through the mobile phone. The information, shared through the mobile phone, covers areas such as dietary advice, and health issues (i.e. treatment of baby cholera – a common cause of infant mortality).
We are excited to share our 2021 Impact Report, which sheds light on critical milestones and achievements from the past year, and the important impact
In November 2021, we invested in Viebeg Technologies - a Rwanda-based health tech company that provides high-quality medical supplies and equipment ac
In September 2021, we did a follow-on investment into our portfolio company ZUMI, based in Kenya. Since our first investment in May 2020, we have been